An observational study in Cerebrovascular Stroke, sponsored by Bnai Zion Medical Center. Status unknown at 1 site in Israel. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-08-14.
Sponsored by Bnai Zion Medical Center · Observational
In patients admitted to hospital with acute cerebrovascular stroke, we want to study the relationship between hair cortisol levels and biomarkers of inflammation and the clinical and radiological severity of the stroke and the degree of neurological disability being tested in three months and one year after.
The study will include patients hospitalized due to an acute cerebrovascular stroke. A number of 30 patients aged 40-70 will be included. Within 48 hours of the event, blood inflammatory biomarkers, and scalp hair sample for cortisol will be taken. All recruited patients will undergo full neurological examination and the severity of the stroke will be rated using NIHSS (National Institutes of Health Stroke Scale). 3 months and one year later neurological examination and rating of neurological disability will be determined using Rankin Scale.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's planned enrollment of 30 is below the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Bnai Zion Medical Center is the lead sponsor of 102 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Anti Tumor Necrosis Factor alpha
single blood sample will be drawn to measure Anti Tumor Necrosis Factor alpha levels (pg/ml).
Time frame: 24 months
C-reactive protein levels
single blood sample will be drawn to measure c-reactive protein levels (mcg/dl).
Time frame: 24 months
Hair Cortisol level
single hair sample will be drawn to measure cortisol levels (mcg/dl)
Time frame: 24 months
INL-6
single blood sample will be drawn to measure INL-6 levels.
Time frame: 24 months
TSH
single blood sample will be drawn to measure Thyroid-Stimulating Hormone (mcIU/ml).
Time frame: 24 months
FT4
single blood sample will be drawn to measure Free Thyroxine (pmol/L) .
Time frame: 24 months
FT3
single blood sample will be drawn to measure Free Triiodothyronine (pmol/L).
Time frame: 24 months
Cortisol
single blood sample will be drawn to measure cortisol levels (mcg/dl).
Time frame: 24 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bnai Zion Medical Center